Drugmaker Sandoz has called for the European Commission to launch an investigation into Chinese imports of a key ingredient used in a popular antibiotic, alleging unfair state subsidies.
The world’s largest maker of generic drugs said Chinese imports of amoxicillin trihydrate, an active ingredient of the most widely used antibiotic in Europe, reflected “significant state intervention” and “non-market pricing”, according to a complaint submitted in March and seen by the FT.
The Swiss group, which was spun off from Novartis in 2023, has asked the Commission for “corrective” measures to protect the EU’s industry and the “resilience of its supply of this key medicinal ingredient”.
您已阅读21%（683字），剩余79%（2578字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。